Sat.Oct 23, 2021 - Fri.Oct 29, 2021

article thumbnail

Merck takes further steps to expand access to oral COVID pill

pharmaphorum

Merck & Co has signed a licensing deal with the UN-backed Medicines Patent Pool (MPP) that could pave the way for generic companies to manufacture its much-anticipated oral antiviral for COVID-19. The agreement would provide royalty-free licenses to companies manufacturing molnupiravir – originally developed by Ridgeback Biotherapeutics – for distribution in 105 low- and middle-income countries around the world.

Hospitals 143
article thumbnail

Alexa is finding a voice in healthcare. Cedars-Sinai, Boston Children's sign on for new Amazon smart hospital service

Fierce Healthcare

Alexa is finding a voice in healthcare. Cedars-Sinai, Boston Children's sign on for new Amazon smart hospital service. hlandi. Sun, 10/24/2021 - 21:46.

Hospitals 133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Potential COVID-19 treatment to wrap up Phase III trial

Outsourcing Pharma

Appili Therapeutics reports it has enrolled the last patient for its Phase III study of Avigan/Reeqonus (favipiravir), developed in alliance with AiPharma.

119
119
article thumbnail

10 Tips On How To Get Started With Agile Marketing

Pharma Marketing Network

What is Agile Marketing Exactly? Agile marketing is the application of agile values and principles to manage the way a marketing team gets work done. At its core, an agile approach values flexibility, iteration, and speed. It enables you to quickly learn what does and does not work, so you can incrementally improve the results of your marketing efforts.*. * Source: AHA!

94
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Bayer, One Drop launch AI tool for heart disease prevention

pharmaphorum

Bayer’s two-year-old digital health collaboration with One Drop has borne its first fruit, an artificial intelligence-powered software module for preventing cardiovascular disease (CVD). The German pharmaceutical company has been working with New York-based One Drop on digital health products that span multiple therapeutic areas, including oncology and women’s health as well as CVD in the alliance , which was expanded last year in a $98 million deal.

article thumbnail

Healthcare is in an era of 'hyper-innovation' as executives look to ramp up digital tech: survey

Fierce Healthcare

Healthcare is in an era of 'hyper-innovation' as executives look to ramp up digital tech: survey. rtorrence. Thu, 10/28/2021 - 16:57.

139
139

More Trending

article thumbnail

The New Killer App? Platforms in Healthcare

Pharma Marketing Network

The healthcare burden continues to increase and the complexity continues to grow. There is a high volume of inefficiencies in the market, which is becoming increasingly fragmented due to the infusion of venture capital dollars over the last five-plus years and the thousands of start-up companies focused on addressing some aspect of healthcare. A digital platform typically refers to a digital service or digital product with an integrated business model and operational model.

article thumbnail

Strike two for Novartis’ lung cancer antibody canakinumab

pharmaphorum

Expectations for Novartis’ canakinumab as a therapy for cancer have taken another dive, after a second phase 3 trial in non-small cell lung cancer (NSCLC) failed to meet its primary objectives. Novartis isn’t giving up on the programme yet, as it still has other trials of canakinumab in play, but the latest failure makes prospects for the antibody in oncology look increasingly remote.

122
122
article thumbnail

Hinge Health bags $600M investment from Coatue, Tiger Global, boosting valuation to $6.2B

Fierce Healthcare

Hinge Health bags $600M investment from Coatue, Tiger Global, boosting valuation to $6.2B. hlandi. Thu, 10/28/2021 - 11:00.

144
144
article thumbnail

Potential COVID-19 treatment to kick off Phase III trial

Outsourcing Pharma

Appili Therapeutics reports it has enrolled the last patient for its Phase III study of Avigan/Reeqonus (favipiravir), developed in alliance with AiPharma.

94
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Petrovax Pharm is taking part in CPhI Worldwide-2021

Pharma Mirror

Petrovax Pharm, the Russian biopharmaceutical company, will participate in CPhI Worldwide-2021 – the international specialized pharmaceutical industry exhibition. This year, it will be held from 9 to 11 November in Italy (Milan) on Fiera Milano territory’s largest exhibition complex. At the exhibition stand, Petrovax Pharm will present its original pharmaceutical products, that are the flagships of the product portfolio – the immunomodulator Polyoxidonium®, the enzyme preparation Lon

article thumbnail

Novartis looking into future of its Sandoz’ generics business

pharmaphorum

Novartis revealed today that it may consider divesting its generic medicines subsidiary Sandoz – amongst other options – which would further narrow its focus to innovative medicines. The company said in its third-quarter results statement that it was weighing options for Sandoz to “maximise shareholder value,” adding that could include retaining the business or a separation – which could involve a spin-off or outright sale.

article thumbnail

Google taps Headspace executive to lead tech-driven mental health efforts

Fierce Healthcare

Google taps Headspace executive to lead tech-driven mental health efforts. hlandi. Tue, 10/26/2021 - 11:58.

143
143
article thumbnail

Speaking the language of diverse patient populations is vital: TransPerfect

Outsourcing Pharma

A leader from the language and tech solutions firm explains how multilingual support can improve patient recruitment and other aspects of clinical trials.

88
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

9 Ways Pharmacists Are Helping the Community

Pharma Mirror

You may not realize it, but your community pharmacist does so much more than fill the prescriptions your primary healthcare provider writes for you. In fact, pharmacists are vital to the health and wellness of the people in the areas they serve on the front line, and they play a key role when it comes to medication adherence. Pharmacists help their communities and, indeed, the medical industry as a whole by administering vaccinations, making drug recommendations, providing access to medical care

article thumbnail

Sustained healthcare systems need sustainable pharma business models

pharmaphorum

COVID-19 demonstrated the importance of robust supply chains and the dangers of an over reliance on overseas manufacturing. But can the Pharmaceutical Strategy for Europe help to redress the balance? Only sustainable, robust supply chains and business models will allow innovation to flourish, secure access to medicines, and minimise the industry’s impact on the environment.

article thumbnail

Clover Health: Open networks encourage patient choice, promote health equity

Fierce Healthcare

Clover Health: Open networks encourage patient choice, promote health equity. rtorrence. Wed, 10/27/2021 - 14:48.

138
138
article thumbnail

Survey: pandemic viewed as catalyst for positive change in trials

Outsourcing Pharma

According to a recent survey from Oracle Health Sciences, 97% of trial professionals say newly adopted approaches will stay in use as we move beyond COVID-19.

84
article thumbnail

Telstar promotes 360º solutions at CPhI Worldwide-2021

Pharma Mirror

Terrassa (Barcelona). Telstar will be actively participating at CPhI, to be held in Milan, during 9-11th November 2021, promoting its personalized GMP consultancy & engineering reply to the new trends in pharma. The company will be displaying high-tech solutions in design, engineering and construction including complete and integrated turnkey pharmaceutical process production facilities, critical installations, clean rooms, biotechnological plants, critical process facilities and R&D lab

52
article thumbnail

Industry welcomes boost to health research in UK budget

pharmaphorum

Groups representing the biopharma industry have welcomed an increase in health-specific R&D to £5 billion in the UK autumn budget, despite a longer timeline for reaching the target of £22 billion in overall R&D spending. The Association of the British Pharmaceutical Industry (ABPI) and BioIndustry Association (BIA) both said that the increase acknowledges the enormous contribution made by the life sciences sector in helping to limit the impact of the pandemic through the rapid developmen

Vaccines 108
article thumbnail

Apps, devices not enough to manage chronic care without patient-doc relationships, Omada Health research finds

Fierce Healthcare

Apps, devices not enough to manage chronic care without patient-doc relationships, Omada Health research finds. rtorrence. Tue, 10/26/2021 - 10:21.

120
120
article thumbnail

Global Genes partners to elevate equity for rare disease patients

Outsourcing Pharma

The radvocacy group is joining with the Rare Disease Diversity Coalition on an initiative to identify and overcome challenges faced by minority patients.

83
article thumbnail

CPhI Annual Report 2021: Short term reshoring the catalyst for longer term manufacturing innovations by 2030

Pharma Mirror

Amsterdam, The second part of the 2021 CPhI Annual Report looks ahead to predict the pharma manufacturing, therapeutic and technology environment in 2030. The analysis foresees the use of automated cobots, AI, real-time release and rapid growth in new areas like mRNA vaccines, alongside the personalization of therapeutics (delivered at far larger scale).

article thumbnail

Luminopia scores FDA approval for TV-based amblyopia therapy

pharmaphorum

Hard on the heels of some impressive clinical trial results, Luminopia has won FDA approval for its digital therapeutic (DTx) for amblyopia or lazy eye in children that is based on watching TV shows. The DTx is TV watching with a difference, of course – namely specially modified TV shows and movies that are viewed using a virtual reality headset designed to promote use of the weaker eye in amblyopia, which is a leading cause of vision loss in children.

FDA 105
article thumbnail

Aetna exec: Retail-based programs connect Medicare members to health resources they trust

Fierce Healthcare

Aetna exec: Retail-based programs connect Medicare members to health resources they trust. dmuoio. Wed, 10/27/2021 - 16:11.

128
128
article thumbnail

How can clinical research be truly patient centric?

Outsourcing Pharma

During OSPâs November 17 online event, a group of experts will offer insights, advice, and examples of solutions that put patients at the center of studies.

81
article thumbnail

Open Enrollment Best Practices

PDS Blog

The final quarter of 2021 presents many opportunities for independent pharmacy owners. With Open Enrollment Season now underway, what plans have you made to assure your patients and your pharmacy are set up for success in 2022? Not sure where to start? Medicare’s Annual Enrollment Period (AEP) is a tremendous opportunity to keep your pharmacy […].

article thumbnail

23andMe makes $400m telehealth play, gulping down Lemonaid

pharmaphorum

Consumer DNA testing company 23andMe has signed a deal to acquire privately-held Lemonaid Health in a $400 million deal that marks a move into the online health sector. Lemonaid operates an on-demand platform for remotely accessing medical care and pharmacy services, including online consultations and prescription medicines delivery across the US. 23andMe – which went public earlier this year through a blank cheque company backed by Virgin Group founder Sir Richard Branson – is making 25% of the

Vaccines 105
article thumbnail

How Optum's HouseCalls pivoted to virtual when houses couldn't be visited during the pandemic

Fierce Healthcare

How Optum's HouseCalls pivoted to virtual when houses couldn't be visited during the pandemic. rking. Wed, 10/27/2021 - 16:33.

127
127
article thumbnail

Increased representation benefits cancer clinical trials: Science 37

Outsourcing Pharma

An expert from the decentralized study solutions company shares perspectives on the importance of inclusivity and solutions that could improve representation.

59
article thumbnail

Marketing Agility – The Path to Digital Engagement & Innovation

Pharma Marketing Network

Pharmaceutical marketing teams are under pressure to move faster – the pandemic changed expectations forever about what can be done and how quickly we can do it. As a result, marketing teams are embracing Agile ways of working. The second panel of the PMN Innovation Summit, Marketing Agility – The Path to Digital Engagement & Innovation, moderated by PMN EAB Member, Amy Turnquist, including an awesome team of industry experts: Jim Lefevre, International Business Leader, Digital Partnering So

52
article thumbnail

EU starts review of Merck’s oral COVID drug molnupiravir

pharmaphorum

The EMA has started a rolling review of Merck & Co and Ridgeback Biotherapeutics’ much-anticipated oral antiviral molnupiravir as a treatment for COVID-19 in adults. Molnupiravir is already filed for approval in the US and Canada – where Merck is known as MSD – amid hopes that the drug could be used to protect vulnerable people with mild or moderate COVID-19 from developing severe disease with a drug that can be delivered outside the hospital.

Hospitals 104
article thumbnail

CHS earnings, revenue hold steady in Q3 despite 'largest number of COVID-19 cases to date'

Fierce Healthcare

CHS earnings, revenue hold steady in Q3 despite 'largest number of COVID-19 cases to date'. dmuoio. Wed, 10/27/2021 - 17:14.

127
127
article thumbnail

Castle Creek Biosciences Collaborates with Mayo Clinic to Expand Gene Therapy Platform

Pharma Mirror

Castle Creek Biosciences Inc., a clinical-stage cell and gene therapy company focused on developing and commercializing disease-modifying therapies for patients suffering from rare diseases for which there is a lack of available treatment options, has formed a new research collaboration with Mayo Clinic. The partnership was forged under the leadership of Castle Creek President and CEO, Mathew Gantz, and direction from Founder and Chairman Jeff Aronin.